Primary tumoral calcinosis without hyperphosphatemia is the most common clinical subtype [13], but approximately 30% of cases are familial and associated with hyperphosphatemia due to the mutation of a gene that encodes fibroblast growth factor-23 or N-acetyl-galactosaminyl transferase enzyme [2, 14]. The gene discussed is FGF23; the disease is hyperphosphatemia.